| Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks J Khan, JS Wei, M Ringner, LH Saal, M Ladanyi, F Westermann, ... Nature Medicine 7 (6), 673-679, 2001 | 3511 | 2001 |
| PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma LH Saal, K Holm, M Maurer, L Memeo, T Su, X Wang, SY Jennifer, ... Cancer Research 65 (7), 2554-2559, 2005 | 1074 | 2005 |
| Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns S Gruvberger, M Ringnér, Y Chen, S Panavally, LH Saal, Ĺ Borg, M Fernö, ... Cancer Research 61 (16), 5979-5984, 2001 | 892 | 2001 |
| The CD44+/CD24-phenotype is enriched in basal-like breast tumors G Honeth, PO Bendahl, M Ringnér, LH Saal, SK Gruvberger-Saal, ... Breast Cancer Research 10 (3), 1-12, 2008 | 686 | 2008 |
| Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity LH Saal, P Johansson, K Holm, SK Gruvberger-Saal, QB She, M Maurer, ... Proceedings of the National Academy of Sciences 104 (18), 7564-7569, 2007 | 620 | 2007 |
| BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data LH Saal, C Troein, J Vallon-Christersson, S Gruvberger, Ĺ Borg, ... Genome biology 3, 1-6, 2002 | 551 | 2002 |
| Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease E Olsson, C Winter, A George, Y Chen, J Howlin, MHE Tang, M Dahlgren, ... EMBO molecular medicine 7 (8), 1034-1047, 2015 | 438 | 2015 |
| Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair LH Saal, SK Gruvberger-Saal, C Persson, K Lövgren, M Jumppanen, ... Nature Genetics 40 (1), 102-107, 2007 | 424 | 2007 |
| cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene J Khan, ML Bittner, LH Saal, U Teichmann, DO Azorsa, GC Gooden, ... Proceedings of the National Academy of Sciences 96 (23), 13264-13269, 1999 | 392 | 1999 |
| Expression profiling in cancer using cDNA microarrays J Khan, LH Saal, ML Bittner, Y Chen, JM Trent, PS Meltzer ELECTROPHORESIS: An International Journal 20 (2), 223-229, 1999 | 278 | 1999 |
| Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a B Fine, C Hodakoski, S Koujak, T Su, LH Saal, M Maurer, B Hopkins, ... Science 325 (5945), 1261, 2009 | 243 | 2009 |
| CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers E Olsson, G Honeth, PO Bendahl, L Saal, S Gruvberger-Saal, M Ringnér, ... BMC Cancer 11 (1), 418, 2011 | 235 | 2011 |
| Estrogen receptor β expression is associated with tamoxifen response in ERα-negative breast carcinoma SK Gruvberger-Saal, PO Bendahl, LH Saal, M Laakso, C Hegardt, P Edén, ... Clinical Cancer Research 13 (7), 1987-1994, 2007 | 231 | 2007 |
| Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study J Staaf, D Glodzik, A Bosch, J Vallon-Christersson, C Reuterswärd, ... Nature medicine 25 (10), 1526-1533, 2019 | 210 | 2019 |
| Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes K Holm, D Grabau, K Lövgren, S Aradottir, S Gruvberger-Saal, J Howlin, ... Molecular oncology 6 (5), 494-506, 2012 | 178 | 2012 |
| Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy H Cirenajwis, H Ekedahl, M Lauss, K Harbst, A Carneiro, J Enoksson, ... Oncotarget 6 (14), 12297, 2015 | 171 | 2015 |
| 3-Phosphoinositide–dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma M Maurer, T Su, LH Saal, S Koujak, BD Hopkins, CR Barkley, J Wu, ... Cancer Research 69 (15), 6299-6306, 2009 | 163 | 2009 |
| Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic C Winter, MP Nilsson, E Olsson, AM George, Y Chen, A Kvist, T Törngren, ... Annals of Oncology 27 (8), 1532-1538, 2016 | 151 | 2016 |
| Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling P Roswall, M Bocci, M Bartoschek, H Li, G Kristiansen, S Jansson, S Lehn, ... Nature medicine 24 (4), 463-473, 2018 | 150 | 2018 |
| The Sweden Cancerome Analysis Network-Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the … LH Saal, J Vallon-Christersson, J Häkkinen, C Hegardt, D Grabau, ... Genome medicine 7 (1), 1-12, 2015 | 150 | 2015 |
Ĺke BorgDepartment of Oncology, Clinical Sciences, Lund University, SwedenVerified email at med.lu.se
